New Revolution in Immunology: PDAC model

Abstract

Several diseases undergo diagnosis difficulty due to complex pathology and the problem is aggravated due to patients developing resistance to current methods of treatment. Therefore, the need of the hour is the discovery of alternative diagnosis and treatment modules and immunoprofiling holds great promise in this respect. This issue has been discussed in this review with PDAC (Pancreatic Ductal Adenocarcinoma) as a complex disease model with common recurrence and diagnosis and treatment obstacles.